SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-24-064465
Filing Date
2024-03-11
Accepted
2024-03-11 09:55:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d803945dposam.htm POS AM 23135
  Complete submission text file 0001193125-24-064465.txt   24196
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-271400 | Film No.: 24736830
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)